Predictive role of hepatic venous pressure gradient in bleeding events among patients with cirrhosis undergoing orthotopic liver transplantation

被引:1
|
作者
Giabicani, Mikhael [1 ,2 ]
Joly, Pauline [1 ]
Sigaut, Stephanie [1 ]
Timsit, Clara [1 ]
Devauchelle, Pauline [1 ]
Dondero, Federica [5 ]
Durand, Francois [3 ,4 ]
Froissant, Pierre Antoine [1 ]
Lamamri, Myriam [1 ]
Payance, Audrey [3 ,4 ]
Restoux, Aymeric [1 ]
Roux, Olivier [3 ]
Thibault-Sogorb, Tristan [1 ]
Valainathan, Shantha Ram [3 ]
Lesurtel, Mickael [4 ,5 ]
Rautou, Pierre-Emmanuel [3 ,4 ,6 ]
Weiss, Emmanuel [1 ,4 ]
机构
[1] Hop Beaujon, AP HP, DMU Parabol, Dept Anesthesie Reanimat, Clichy, France
[2] Univ Paris Cite, Paris, France
[3] Hop Beaujon, AP HP, Ctr Reference Malad Vasc Foie, Serv Hepatol,DMU DIGEST,FILFOIE,ERN RARE LIVER, Clichy, France
[4] Univ Paris Cite, Ctr Rech Inflammat, UMR 1149, Inserm, Paris, France
[5] Univ Paris Cite, Beaujon Hosp, AP HP, Dept HPB Surg & Liver Transplantat,DMU DIGEST, Clichy, France
[6] Serv Hepatol, Hop Beaujon 100,Blvd Gen Leclerc, F-92110 Clichy, France
关键词
hepatic venous pressure gradient; liver transplantation; bleeding; cirrhosis; portal hypertension; pre-transplant assessment; INTENSIVE-CARE-UNIT; BLOOD-TRANSFUSION; CLINICAL-PRACTICE; REQUIREMENTS; MANAGEMENT; SURVIVAL; SCORE; STAY;
D O I
10.1016/j.jhepr.2024.101051
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Major bleeding events during orthotopic liver transplantation (OLT) are associated with poor outcomes. The proportion of this risk related to portal hypertension is unclear. Hepatic venous pressure gradient (HVPG) is the gold standard for estimating portal hypertension. The aim of this study was to analyze the ability of HVPG to predict intraoperative major bleeding events during OLT in patients with cirrhosis. Methods: We retrospectively analyzed a prospective database including all patients with cirrhosis who underwent OLT between 2010 and 2020 and had liver and right heart catheterizations as part of their pre -transplant assessment. The primary endpoint was the occurrence of an intraoperative major bleeding event. Results: The 468 included patients had a median HVPG of 17 mmHg [interquartile range, 13-22] and a median MELD on the day of OLT of 16 [11-24]. Intraoperative red blood cell transfusion was required in 72% of the patients (median 2 units transfused), with a median blood loss of 1,000 ml [575-1,50 0]. Major intraoperative bleeding occurred in 156 patients (33%) and was associated with HVPG, preoperative hemoglobin level, severity of cirrhosis at the time of OLT (MELD score, ascites, encephalopathy), hemostasis impairment (thrombocytopenia, lower fibrinogen levels), and complications of cirrhosis (sepsis, acute -on -chronic liver failure). By multivariable regression analysis with backward elimination, HVPG, preoperative hemoglobin level, MELD score, and tranexamic acid infusion were associated with the primary endpoint. Three categories of patients were identi fied according to HVPG: low -risk (HVPG <16 mmHg), high -risk (HVGP > -16 mmHg), and very high -risk (HVPG > -20 mmHg). Conclusions: HVPG predicted major bleeding events in patients with cirrhosis undergoing OLT. Including HVPG as part of pretransplant assessment might enable better anticipation of the intraoperative course. Impact and implications: Major bleeding events during orthotopic liver transplantation (OLT) are associated with poor outcomes but the proportion of this risk related to portal hypertension is unclear. Our work shows that hepatic venous pressure gradient (HVPG), the gold standard for estimating portal hypertension, is a strong predictor of major bleeding events and blood loss volume in patients with cirrhosis undergoing OLT. Three groups of patients can be identi fied according to their risk of major bleeding events: low -risk patients with HVPG <16 mmHg, high -risk patients with HVPG > -16 mmHg, and very high -risk patients with HVPG > -20 mmHg. HVPG could be systematically included in the pre -transplant assessment to anticipate intraoperative course and tailor patient management. (c) 2024 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL). This is an open access article under the CC BY -NC -ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Hepatic venous pressure gradient predicts further decompensation in cirrhosis patients with acute esophageal variceal bleeding
    Vaishnav, Manas
    Biswas, Sagnik
    Swaroop, Shekhar
    Aggarwal, Arnav
    Pathak, Piyush
    Anand, Abhinav
    Shalimar
    JOURNAL OF HEPATOLOGY, 2023, 78 : S297 - S297
  • [22] Hepatic venous pressure gradient in the assessment of portal hypertension before liver resection in patients with cirrhosis
    Boleslawski, E.
    Petrovai, G.
    Truant, S.
    Dharancy, S.
    Duhamel, A.
    Salleron, J.
    Deltenre, P.
    Lebuffe, G.
    Mathurin, P.
    Pruvot, F. R.
    BRITISH JOURNAL OF SURGERY, 2012, 99 (06) : 855 - 863
  • [23] Effect factors analysis of propranolol decreasing hepatic venous pressure gradient in patients with liver cirrhosis
    段旭红
    China Medical Abstracts(Internal Medicine), 2016, 33 (03) : 168 - 169
  • [24] A non-invasive predictive model based on CT radiomics for hepatic venous pressure gradient in liver cirrhosis
    Guo, Xu
    Cai, Wuque
    Tong, Huan
    Han, Tingrui
    He, Jiayi
    Sun, Hongze
    Zhang, Guiying
    Quan, Xin
    Qian, Shuaijie
    Li, Ying
    Wei, Bo
    Tai, Yang
    Guo, Daqing
    Wu, Hao
    JOURNAL OF HEPATOLOGY, 2024, 80 : S622 - S622
  • [25] Hepatic disposition of alfentanil and sufentanil in patients undergoing orthotopic liver transplantation
    RaucoulesAime, M
    Kaidomar, M
    Levron, JC
    LeMoing, JP
    Goubaux, B
    Gugenheim, J
    Grimaud, D
    ANESTHESIA AND ANALGESIA, 1997, 84 (05): : 1019 - 1024
  • [26] Diagnosing and monitoring cirrhosis: Liver biopsy, hepatic venous pressure gradient and elastography
    Abraldes, Juan G.
    Araujo, Isis K.
    Turon, Fanny
    Berzigotti, Annalisa
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2012, 35 (07): : 488 - 495
  • [27] PREDICTORS OF MAJOR ADVERSE EVENTS IN PATIENTS UNDERGOING ORTHOTOPIC LIVER TRANSPLANTATION
    Fitzgerald, Patrick
    Ray, Jordan
    Pollak, Peter
    Pungapong, Surakit
    Racho, Ronald
    Gharacholou, S.
    Parikh, Pragnesh
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 1846 - 1846
  • [28] Sildenafil does not influence hepatic venous pressure gradient in patients with cirrhosis
    Clemmesen, Jens Otto
    Giraldi, Annamaria
    Ott, Peter
    Dalhoff, Kim
    Hansen, Bent Adel
    Larsen, Fin Stolze
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (40) : 6208 - 6212
  • [29] Sildenafil does not influence hepatic venous pressure gradient in patients with cirrhosis
    Jens Otto Clemmesen
    Annamaria Giraldi
    Peter Ott
    Kim Dalhoff
    Bent Adel Hansen
    Fin Stolze Larsen
    World Journal of Gastroenterology, 2008, (40) : 6208 - 6212